SCHEMBL7987938

SCHEMBL7987938

CCC(=O)Nc1ncn(Cc2ccccc2F)c1C(N)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
KMT2A Q03164 1/20 0.44
PDE4A P27815 6/20 0.43
PDE4B Q07343 6/20 0.43
PDE4C Q08493 6/20 0.43
PDE4D Q08499 6/20 0.43
PDE5A O76074 3/20 0.43
PDE1A P54750 3/20 0.43
PDE1B Q01064 3/20 0.43
PDE1C Q14123 3/20 0.43
PDE3B Q13370 2/20 0.43
PDE3A Q14432 2/20 0.43
TP53 P04637 3/20 0.43
LMNA P02545 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
RAB9A P51151 2/20 0.41
PPARG P37231 1/20 0.41
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984433 0.87 SMN1; SMN2 (0.47) KDM4EMEN1ALDH1A1KMT2ATP53
SCHEMBL7987920 0.84 TP53 (0.47) KDM4EMEN1ALDH1A1KMT2APDE4A
SCHEMBL7984751 0.84 NTRK1 (0.46) KDM4EMEN1ALDH1A1KMT2APDE4A
SCHEMBL7991565 0.83 TSHR (0.49) KDM4EALDH1A1KMT2APDE4APDE4B
SCHEMBL7989013 0.81 TP53 (0.38) KDM4EMEN1ALDH1A1KMT2APDE4A
SCHEMBL7985670 0.80 CDK9 (0.42) KDM4EALDH1A1KMT2ALMNAMAPT
SCHEMBL7988641 0.80 KMT2A (0.44) KDM4EMEN1ALDH1A1KMT2ALMNA
SCHEMBL7974172 0.79 HDAC3 (0.44) ALDH1A1LMNARAB9AL3MBTL1ADORA3
SCHEMBL7974324 0.79 TNF (0.44) KDM4EMEN1ALDH1A1KMT2ATP53
SCHEMBL18050884 0.78 ATM (0.44) ALDH1A1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed